HENDERSON, NV, June 01, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioLife Sciences Inc. (OTC:BLFE) (the “Company” or “BioLife”), announced today that it has filed Form 1-A with the Securities and Exchange Commission (SEC) seeking to raise up to $20 million under a Tier I Regulation A+ offering.
Read more at globenewswire.comBioLife Sciences Inc. Files Form 1-A with the Securities and Exchange Commission (SEC) to Raise Capital Under a Tier I Regulation A+ Offering
Globe Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
/Intel%20Corp_%20logo%20on%20mobile%20phone-by%20Piotr%20Swat%20via%20Shutterstock.jpg)
/An%20image%20of%20a%20Tesla%20humanoid%20robot%20in%20front%20of%20the%20company%20logo%20Around%20the%20World%20Photos%20via%20Shutterstock.jpg)
/Alphabet%20(Google)%20Image%20by%20Markus%20Mainka%20via%20Shutterstock.jpg)
/Nvidia%20logo%20by%20Konstantin%20Savusia%20via%20Shutterstock.jpg)
/Micron%20Technology%20Inc_%20logo%20on%20building-by%20vzphotos%20vis%20iStock.jpg)